Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Bafilomycin B1

Bafilomycin B1

Bafilomycin B1 structure

Bafilomycin B1 

structure
  • CAS No:

    88899-56-3

  • Formula:

    C44H65NO13

  • Chemical Name:

    Bafilomycin B1

  • Synonyms:

    2-Butenoic acid,4-[(2-hydroxy-5-oxo-1-cyclopenten-1-yl)amino]-4-oxo-,(2R,4R,5S,6R)-tetrahydro-2-hydroxy-2-[(1S,2R,3S)-2-hydroxy-3-[(2R,3S,4E,6E,9S,10S,11R,12E,14Z)-10-hydroxy-3,15-dimethoxy-7,9,11,13-tetramethyl-16-oxooxacyclohexadeca-4,6,12,14-tetraen-2-yl]-1-methylbutyl]-5-methyl-6-(1-methylethyl)-2H-pyran-4-yl ester,(2E)-;Hygrolidin,37-decarboxy-2-demethyl-37-[[(2-hydroxy-5-oxo-1-cyclopenten-1-yl)amino]carbonyl]-2-methoxy-24-methyl-;Oxacyclohexadecane,hygrolidin deriv.;Bafilomycin B1;Setamycin;2-Butenoic acid,4-[(2-hydroxy-5-oxo-1-cyclopenten-1-yl)amino]-4-oxo-,tetrahydro-2-hydroxy-2-[2-hydroxy-3-(10-hydroxy-3,15-dimethoxy-7,9,11,13-tetramethyl-16-oxooxacyclohexadeca-4,6,12,14-tetraen-2-yl)-1-methylbutyl]-5-methyl-6-(1-methylethyl)-2H-pyran-4-yl ester,[2R-[2R*[1S*[2R*,4R*(E),5S*,6R*],2R*,3S*],3S*,4E,6E,9S*,10S*,11R*,12E,14Z]]-;80112-34-1

  • Categories:

    Active Pharmaceutical Ingredients  >  Synthetic Anti-infective Drugs

Description

Bafilomycin B1 is a macrolide antibiotic isolated from Streptomyces sp, inhibits Gram-positive bacteria and fungi, and acts as an inhibitor of K+-dependent ATPase of E. coli[1].

Bafilomycin B1 Basic Attributes

815.99

815.99

Characteristics

207.38000

3.06

faint yellow to yellow

1.2±0.1 g/cm3

939.4±65.0 °C at 760 mmHg

521.9±34.3 °C

1.563

−20°C

Safety Information

3

UN 3462 6.1/PG 1

3

26/27/28

36/37/39-45

NG8841000

T+

P260-P264-P280-P284-P301 + P310-P302 + P350

H300 + H310 + H330

Bafilomycin B1 Use and Manufacturing

Bafilomycin B1 is a member of a potent family of macrocyclic lactones.Bafilomycin B1 shares the same mode of action and activity as its more accessible A1 analogue. Bafilomycin B1 is broadly active against bacteria, fungi, insects, nematodes and protozoans. Bafilomycin B1 has attracted interest as a potential agent for treating osteoporosis.

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.